Kiniksa Pharmaceuticals Stock Price on February 1, 2025
| KNSA Stock | USD 21.39 0.06 0.28% |
If you're considering investing in Kiniksa Stock, it is important to understand the factors that can impact its price. As of today, the current price of Kiniksa Pharmaceuticals stands at 21.39, as last reported on the 5th of March, with the highest price reaching 22.02 and the lowest price hitting 21.10 during the day. At this point, Kiniksa Pharmaceuticals is very steady. Kiniksa Pharmaceuticals has Sharpe Ratio of 0.0254, which conveys that the firm had a 0.0254 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Kiniksa Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Kiniksa Pharmaceuticals' Downside Deviation of 2.79, mean deviation of 1.78, and Risk Adjusted Performance of 0.0266 to check out if the risk estimate we provide is consistent with the expected return of 0.0616%.
Kiniksa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Kiniksa |
Sharpe Ratio = 0.0254
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | KNSA | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.43 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Kiniksa Pharmaceuticals is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kiniksa Pharmaceuticals by adding it to a well-diversified portfolio.
Kiniksa Pharmaceuticals Valuation on February 1, 2025
It is possible to determine the worth of Kiniksa Pharmaceuticals on a given historical date. On February 1, 2025 Kiniksa was worth 20.1 at the beginning of the trading date compared to the closed value of 19.6. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kiniksa Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Kiniksa Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kiniksa Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kiniksa Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 20.83 | 20.83 | 19.76 | 19.88 | 547,223 | |
01/31/2025 | 20.10 | 20.10 | 19.55 | 19.60 | 570,334 |
| 19.58 | 19.60 | 18.85 | 18.88 | 555,432 |
| Backtest Kiniksa Pharmaceuticals | | | Kiniksa Pharmaceuticals History | | | Kiniksa Pharmaceuticals Valuation | Previous | Next |
Kiniksa Pharmaceuticals Trading Date Momentum on February 1, 2025
| On February 03 2025 Kiniksa Pharmaceuticals was traded for 18.88 at the closing time. The top price for the day was 19.60 and the lowest listed price was 18.85 . The trading volume for the day was 555.4 K. The trading history from February 3, 2025 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.67% . The trading delta at closing time against the current closing price is 0.10% . |
Kiniksa Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Kiniksa Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kiniksa Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kiniksa financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Kiniksa Pharmaceuticals Stock history
Kiniksa Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kiniksa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kiniksa Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kiniksa Pharmaceuticals stock prices may prove useful in developing a viable investing in Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Kiniksa Pharmaceuticals, Ltd. was incorporated in 2015 and is based in Hamilton, Bermuda. Kiniksa Pharmaceuticals is traded on NASDAQ Exchange in the United States.
Kiniksa Pharmaceuticals Stock Technical Analysis
Kiniksa Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Kiniksa Pharmaceuticals Period Price Range
Low | March 5, 2025
| High |
0.00 | 0.00 |
Kiniksa Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Kiniksa Pharmaceuticals March 5, 2025 Market Strength
Market strength indicators help investors to evaluate how Kiniksa Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kiniksa Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Kiniksa Pharmaceuticals stock market strength indicators, traders can identify Kiniksa Pharmaceuticals entry and exit signals to maximize returns
Kiniksa Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kiniksa Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Kiniksa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kiniksa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0266 | |||
| Jensen Alpha | 0.0744 | |||
| Total Risk Alpha | 0.2569 | |||
| Sortino Ratio | 0.0422 | |||
| Treynor Ratio | 0.1492 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Kiniksa Stock analysis
When running Kiniksa Pharmaceuticals' price analysis, check to measure Kiniksa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiniksa Pharmaceuticals is operating at the current time. Most of Kiniksa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiniksa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiniksa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiniksa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |